Kyverna Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights – KYTXAccesswire • 12/19/24
KYTX INVESTOR DEADLINE: Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitPRNewsWire • 12/19/24
Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Class Action Lawsuit Against Kyverna Therapeutics, Inc.PRNewsWire • 12/19/24
KYTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!Accesswire • 12/19/24
Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights - KYTXPRNewsWire • 12/19/24
The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc.Accesswire • 12/19/24
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Kyverna Therapeutics, Inc. - KYTXAccesswire • 12/19/24
Levi & Korsinsky Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – KYTXAccesswire • 12/19/24
KYTX Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc.Business Wire • 12/19/24
KYTX LAWSUIT ALERT: The Gross Law Firm Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineGlobeNewsWire • 12/18/24
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kyverna Therapeutics, Inc. (KYTX)Business Wire • 12/18/24
KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!Accesswire • 12/18/24
Shareholders that Lost Money on Kyverna Therapeutics, Inc. (KYTX) Should Contact Levi & Korsinsky about Pending Class Action - KYTXAccesswire • 12/18/24
Shareholders that lost money on Kyverna Therapeutics, Inc.(KYTX) should contact Levi & Korsinsky about pending Class Action - KYTXAccesswire • 12/18/24
Kyverna Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Assist The Schall Law FirmAccesswire • 12/18/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc. (KYTX) InvestorsBusiness Wire • 12/17/24
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTXGlobeNewsWire • 12/17/24
Investors Who Lost Money on Kyverna Therapeutics, Inc. (KYTX) Should Contact Levi & Korsinsky About Pending Class Action - KYTXAccesswire • 12/17/24
Class Action Filed Against Kyverna Therapeutics, Inc. (KYTX) Seeking Recovery for Investors – Contact Levi & KorsinskyAccesswire • 12/17/24
The Schall Law Firm Urges Stockholder Participation In A Securities Fraud Case Against Kyverna Therapeutics IncAccesswire • 12/16/24
Kirby McInerney LLP Reminds Kyverna Therapeutics, Inc. (KYTX) Investors of Class Action Filing and Encourages Investors to Contact the FirmGlobeNewsWire • 12/16/24
KYTX INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire • 12/16/24
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. Lawsuit - KYTXPRNewsWire • 12/16/24
Kyverna Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Contact The Schall Law FirmAccesswire • 12/16/24
KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitGlobeNewsWire • 12/15/24
